Curavit Clinical Research Launches DEI Planning Toolkit
Virtual CRO seeks to help life sciences companies meet new federal guidelines for diversity, equity, and inclusion in clinical trials.
Curavit Clinical Research has announced its Inclusivity, Diversity, and Equity in Action (IDEA) toolkit. IDEA is a clinical trial planning and support service designed to help clinical trial sponsors navigate challenges in developing and executing diversity action plans, now required by law for most clinical trials in the United States. Curavit's IDEA toolkit delivers support across five key functional areas:
- Preliminary Situational Analysis
- DEI Implementation Strategy
- Content Review
- Continuous Check-Ins
- Ongoing Optimization
Two early adopters of Curavit's new service offering have leveraged planning templates to ensure that they were familiar with the underrepresented patient populations that would be important to include in the trial, to compile effective strategies to recruit diverse groups of patients for enrollment, and to identify potential sites and investigators already engaged with the desired patient populations.
Reference
Curavit Clinical Research Launches First Clinical Trial DEI Planning Toolkit. (2023, June 21). Cision PR Newswire.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
